Clinical Trials Directory

Trials / Sponsors / Brainstorm-Cell Therapeutics

Brainstorm-Cell Therapeutics

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingEfficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presen
Amyotrophic Lateral Sclerosis (ALS), Amyotrophic Lateral Sclerosis
Phase 32025-06-30
CompletedSafety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS
Multiple Sclerosis, Chronic Progressive
Phase 22019-03-13
CompletedSafety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients
Amyotrophic Lateral Sclerosis (ALS)
Phase 32017-08-28
CompletedPhase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patient
Amyotrophic Lateral Sclerosis (ALS)
Phase 22014-05-01
CompletedAutologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Am
Amyotrophic Lateral Sclerosis
Phase 22012-12-01
CompletedAutologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Pat
Amyotrophic Lateral Sclerosis
Phase 1 / Phase 22011-06-01
No Longer AvailableExpanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of A
Amyotrophic Lateral Sclerosis
——